You just read:

Phase 2 Results on Efficacy of PMZ-2010 (Centhaquin) in Patients with Hypovolemic Shock Presented at AHA Scientific Sessions 2018

News provided by

Pharmazz, Inc.

Nov 12, 2018, 14:51 ET